UPLYFT For Lymphoma Survivors
Completed · Not applicable
Conditions studied: Lymphoma, Survivorship
In brief
The main purpose of this study is to field test and pilot an intervention called UPLYFT (Understand and Prevail: Lymphoma Fear of Recurrence Therapy) that includes information about lymphoma survivorship and tools to improve quality of life and reduce lymphoma-related worries among lymphoma survivors.
Key facts
- Study ID
- NCT05080166
- Run by
- Dana-Farber Cancer Institute
- People needed
- 74
- Starts
- 2022-02-08
- Expected to finish
- 2026-07-17
- Last updated by the study team
- 2026-08-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Lymphoma Survivors Phase 1 and 2:
- Diagnosis of lymphoma (indolent non-Hodgkin lymphoma, aggressive non-Hodgkin lymphoma, or classic Hodgkin lymphoma)
- Age ≥ 18 years
- Interval of 3 months to 24 months from completion of first-line treatment
- In complete remission after first line of treatment
- Clinically significant FCR (score of ≥ 16 on the validated FCR Inventory-Severity Subscale [FCRI-SS).
- Access to computer (for videoconferencing)
- Lymphoma clinicians and mental health clinicians Phase 1:
- Lymphoma clinicians ≥ 1 year from oncology fellowship completion OR mental health clinicians (psychologists, social workers, psychiatrists) ≥ 1 year from completion of clinical training.
- Longitudinal clinical care for patients with lymphoma by oncologists OR provision of care for patients with cancer by mental health clinicians
You may not qualify if…
- Lymphoma Survivors Phase 1:
- Age < 18 years
- Concurrent other malignancy
- Patients with uncontrolled/untreated psychotic disorders or untreated bipolar and borderline personality disorder (as ascertained from medical record screen).
- Lymphoma Survivors Phase 2:
- Age < 18 years
- Concurrent other malignancy
- Patients with uncontrolled/untreated psychotic disorders or untreated bipolar and borderline personality disorders (as ascertained from medical record screen).
- Our study will exclude members of the following special populations:
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Prisoners
Where it is running
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.